Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy

NCT06916104 is registered in ClinicalTrials.gov with Poitiers University Hospital as lead sponsor.

NCT NCT06916104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06916104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Respiratory Allergy on Response to Initiation of Biotherapy in Severe Asthma in Adult Severe Asthmatic Patients Followed at Poitiers University Hospital on Biotherapy
Lead sponsor
Poitiers University Hospital
Phase
Observational
Overall status
Enrolling by invitation
Start date
March 1, 2024
Completion date
March 31, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biotherapy, respiratory allergy, severe asthma